AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2008–2017

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2017	—	1	1
2016	—	4	1
2015	—	4	1
2014	—	4	1
2013	—	5	1
2012	—	4	1
2011	—	4	1
2010	—	4	1
2009	—	4	1
2008	—	7	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
CONSTANTINE CANNON LLP	—	41

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	15
HOUSE OF REPRESENTATIVES	12
Justice, Dept of (DOJ)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	13
Copyright/Patent/Trademark	Copyright/Patent/Trademark	13
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	6
Pharmacy	Pharmacy	6
Budget/Appropriations	Budget/Appropriations	1
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	1
Science/Technology	Science/Technology	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 2112th Congress

Repealing the Job-Killing Health Care Law Act

2011 · fourth_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act

Client expense: — · Firm income: $50,000

Matched citations: H.R. 2

H.R. 2632112th Congress

Life Sciences Jobs and Investment Act of 2011

2011 · fourth_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act

Client expense: — · Firm income: $50,000

Matched citations: H.R.2632

H.R. 2672112th Congress

Preserving Access to Orphan Drugs Act of 2011

2011 · fourth_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act

Client expense: — · Firm income: $50,000

Matched citations: H.R.2672

H.R. 2674112th Congress

340B Program Improvement Act

2011 · fourth_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act

Client expense: — · Firm income: $50,000

Matched citations: H.R.2674

Show 21 more cited filings

H.R. 2112th Congress

Repealing the Job-Killing Health Care Law Act

2011 · third_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act

Client expense: — · Firm income: $50,000

Matched citations: H.R. 2

H.R. 2632112th Congress

Life Sciences Jobs and Investment Act of 2011

2011 · third_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act

Client expense: — · Firm income: $50,000

Matched citations: H.R.2632

H.R. 2672112th Congress

Preserving Access to Orphan Drugs Act of 2011

2011 · third_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act

Client expense: — · Firm income: $50,000

Matched citations: H.R.2672

H.R. 2674112th Congress

340B Program Improvement Act

2011 · third_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act

Client expense: — · Firm income: $50,000

Matched citations: H.R.2674

H.R. 2112th Congress

Repealing the Job-Killing Health Care Law Act

2011 · second_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 319 -- drug reimportation H.R. 2 -- healthcare reform bill repeal PDUFA reauthorization; Life sciences research tax credit legislation Orphan drug issues

Client expense: — · Firm income: $50,000

Matched citations: H.R. 2

H.R. 2112th Congress

Repealing the Job-Killing Health Care Law Act

2011 · first_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 319 -- drug reimportation H.R. 2 -- healthcare reform bill repeal PDUFA reauthorization; Life sciences research tax credit legislation Orphan drug issues

Client expense: — · Firm income: $50,000

Matched citations: H.R. 2

H.R. 1191111th Congress

Safe Drug Disposal Act of 2009

2010 · fourth_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1191

H.R. 1260111th Congress

Patent Reform Act of 2009

2010 · fourth_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1260

H.R. 1298111th Congress

Pharmaceutical Market Access and Drug Safety Act of 2009

2010 · fourth_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1298

H.R. 1359111th Congress

Secure and Responsible Drug Disposal Act of 2009

2010 · fourth_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1359

H.R. 1706111th Congress

Protecting Consumer Access to Generic Drugs Act of 2009

2010 · fourth_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1706

H.R. 5712111th Congress

Physician Payment and Therapy Relief Act of 2010

2010 · fourth_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation

Client expense: — · Firm income: $60,000

Matched citations: H.R. 5712

H.R. 6165111th Congress

Life Sciences Jobs and Investment Act of 2010

2010 · fourth_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation

Client expense: — · Firm income: $60,000

Matched citations: H.R. 6165

S. 1292111th Congress

Secure and Responsible Drug Disposal Act of 2009

2010 · fourth_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation

Client expense: — · Firm income: $60,000

Matched citations: S. 1292

S. 1336111th Congress

Safe Drug Disposal Act of 2009

2010 · fourth_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation

Client expense: — · Firm income: $60,000

Matched citations: S. 1336

S. 369111th Congress

Preserve Access to Affordable Generics Act

2010 · fourth_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform

Client expense: — · Firm income: $60,000

Matched citations: S. 369

S. 4018111th Congress

Life Sciences Jobs and Investment Act of 2010

2010 · fourth_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation

Client expense: — · Firm income: $60,000

Matched citations: S. 4018

S. 515111th Congress

Patent Reform Act of 2009

2010 · fourth_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform

Client expense: — · Firm income: $60,000

Matched citations: S. 515

S. 525111th Congress

Pharmaceutical Market Access and Drug Safety Act of 2009

2010 · fourth_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation

Client expense: — · Firm income: $60,000

Matched citations: S. 525

H.R. 1191111th Congress

Safe Drug Disposal Act of 2009

2010 · third_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336, H.R. 5809, S. 3397 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165 - Life sciences research tax credit legislation H.R. 6165 - Life Sciences research tax credit legislation.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1191

H.R. 1260111th Congress

Patent Reform Act of 2009

2010 · third_quarter · Firm: CONSTANTINE CANNON LLP

Open original LDA filing ↗

Cited source text and reported amounts

S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1260

Source: Senate LDA

AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) — Lobbying Disclosure | Poliscope